(Q36174291)

12 August 2017

1 reference

title

D-hormone analog alfacalcidol: an update on its role in post-menopausal osteoporosis and rheumatoid arthritis management (English)

1 reference

12 August 2017

1 reference

6

Jean-Yves Reginster

1 reference

12 August 2017

Florent Richy

1

1 reference

12 August 2017

Rita Deroisy

2

1 reference

12 August 2017

Marie-Paule Lecart

3

1 reference

12 August 2017

Linda Hanssens

4

1 reference

12 August 2017

Audrey Mawet

5

1 reference

12 August 2017

publication date

1 April 2005

1 reference

Aging Clinical and Experimental Research

12 August 2017

published in

1 reference

12 August 2017

volume

17

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

133-142

1 reference

25-Hydroxyvitamin D3 1alpha-hydroxylase and vitamin D synthesis

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Complete structure of the human gene for the vitamin D 1alpha-hydroxylase, P450c1alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Membrane actions of vitamin D metabolites 1alpha,25(OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Three-fold induction of renal 25-hydroxyvitamin D3-24-hydroxylase activity and increased serum 24,25-dihydroxyvitamin D3 levels are correlated with the healing process after chick tibial fracture

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Expression and activity of vitamin D-metabolizing cytochrome P450s (CYP1alpha and CYP24) in human nonsmall cell lung carcinomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Identification of a novel rat microsomal vitamin D3 25-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

CYP3A4 is a human microsomal vitamin D 25-hydroxylase

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

New concepts of vitamin D functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D in preventive medicine: are we ignoring the evidence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D status and sex hormone binding globulin: determinants of bone turnover and bone mineral density in elderly women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D and the parathyroid

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D therapy of osteoporosis: plain vitamin D therapy versus active vitamin D analog (D-hormone) therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

25-Hydroxylation of vitamin D3 in primary cultures of pig hepatocytes: evidence for a role of both CYP2D25 and CYP27A1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

In vivo administration of 1,25‐dihydroxyvitamin D3 suppresses the expression of RANKL mRNA in bone of thyroparathyroidectomized rats constantly infused with PTH

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Response of parathyroid glands to calcitriol in culture: Is this response mediated by the genetic polymorphisms in vitamin D receptor?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Abnormalities of parathyroid hormone secretion in elderly women that are reversible by short term therapy with 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

The hyperparathyroidism of chronic renal failure: a disorder of growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Steroid receptor specificity with reference to the estrogen receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Pretreatment with 1,25(OH)2 vitamin D or 24,25(OH)2 vitamin D increases synergistically responsiveness to sex steroids in skeletal-derived cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Interaction effects between estrogen receptor alpha gene, vitamin D receptor gene, age, and sex on bone mineral density in Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

24,25-Dihydroxyvitamin D(3) and bone metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Osteoprotegerin production by human osteoblast lineage cells is stimulated by vitamin D, bone morphogenetic protein-2, and cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

The effect of 1,25(OH)2 vitamin D3 on CD4+/CD8+ subsets of T lymphocytes in postmenopausal women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Efficacy of alphacalcidol and calcitriol in primary and corticosteroid-induced osteoporosis: a meta-analysis of their effects on bone mineral density and fracture rate

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D analogs versus native vitamin D in preventing bone loss and osteoporosis-related fractures: a comparative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Amelioration of osteopenia and hypovitaminosis D by 1alpha-hydroxyvitamin D3 in elderly patients with Parkinson's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Role of calcitriol in the treatment of postmenopausal osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Alfacalcidol and calcitriol in the prevention of bone loss after organ transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Hip fracture patients, a group of frail elderly people with low bone mineral density, muscle mass and IGF-I levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Skeletal Muscle Calcium Metabolism and Contractile Force in Vitamin D-deficient Chicks

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

In situ detection of 1,25-dihydroxyvitamin D3 receptor in human skeletal muscle tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Muscle strength in the elderly: its relation to vitamin D metabolites.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Muscle weakness in intensive care patients: initial manifestation of vitamin D deficiency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

The vitamin D receptor mediates rapid changes in muscle protein tyrosine phosphorylation induced by 1,25(OH)(2)D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Low vitamin D and high parathyroid hormone levels as determinants of loss of muscle strength and muscle mass (sarcopenia): the Longitudinal Aging Study Amsterdam

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Low vitamin D status: a contributing factor in the pathogenesis of congestive heart failure?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

1,25-Dihydroxyvitamin D3 and muscle strength in the elderly: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Effects of vitamin D and calcium supplementation on falls: a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Alfacalcidol reduces the number of fallers in a community-dwelling elderly population with a minimum calcium intake of more than 500 mg daily

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Immunomodulatory actions of 1,25-dihydroxyvitamin D3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Vitamin D and autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

A Crucial Role for the Vitamin D Receptor in Experimental Inflammatory Bowel Diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

A composite element binding the vitamin D receptor and the retinoic X receptor alpha mediates the transforming growth factor-beta inhibition of decorin gene expression in articular chondrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Effects of rheumatoid arthritis on bone

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Osteoclast formation and activity in the pathogenesis of osteoporosis in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Involvement of interleukin-6 and prostaglandin E2 in periarticular osteoporosis of postmenopausal women with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Animal models of rheumatoid arthritis and related inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Cytokine levels in serum of patients with juvenile rheumatoid arthritis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Potential clinical relevance of digital radiogrammetry for quantification of periarticular bone demineralization in patients suffering from rheumatoid arthritis depending on severity and compared with DXA

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

1,25(OH)2D3 increases cytotoxicity and exocytosis in lymphokine-activated killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Management of glucocorticoid-induced osteoporosis in patients with rheumatoid arthritis: rates and predictors of care in an academic rheumatology practice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Alphacalcidol in prevention of glucocorticoid-induced osteoporosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

21 January 2018

Growth hormone and bone

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Effects of growth hormone and insulin-like growth factors on human osteoblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Effect of Glucocorticoids and 1,25-Dihydroxyvitamin D3on the Developmental Expression of the Rat Intestinal Vitamin D Receptor Gene*

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Glucocorticoids decrease vitamin D receptor number and gene expression in human osteosarcoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FBF03324586

Amelioration of hemiplegia-associated osteopenia more than 4 years after stroke by 1 alpha-hydroxyvitamin D3 and calcium supplementation

21 January 2018

1 reference

3 January 2024

https://opencitations.net/index/api/v1/citations/10.1161/01.STR.28.4.736

Identifiers

DOI

10.1007/BF03324586

1 reference

12 August 2017

1 reference